Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-06-2022 | Bronchoscopy | Case report

Ivermectin

Gene polymorphism: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Honigman A, et al. Strongyloides hyperinfection syndrome following negative strongyloides serology in a patient immunosuppressed for the treatment of severe pemphigus vulgaris. Australasian Journal of Dermatology 63 (Suppl.): 62-63, May 2022. Available from: URL: http://doi.org/10.1111/ajd.13_13832 Honigman A, et al. Strongyloides hyperinfection syndrome following negative strongyloides serology in a patient immunosuppressed for the treatment of severe pemphigus vulgaris. Australasian Journal of Dermatology 63 (Suppl.): 62-63, May 2022. Available from: URL: http://​doi.​org/​10.​1111/​ajd.​13_​13832
Metadata
Title
Ivermectin
Gene polymorphism: case report
Publication date
01-06-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-17961-7

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Methotrexate

Case report

Empagliflozin

Case report

Tozinameran

Case report

Rituximab